Senior Quantitative Biomarker Scientist
Regeneron Pharmaceuticals
Summary
This is a statistical computational role within Precision Medicine Quantitative Translational Sciences (PMQTS), the analytical arm of Precision Medicine. The role involves clinical trial data management and data analysis, including exploratory analyses and visualization of omics, EHR, wearable sensor, imaging, and other biomarker data, as well as developing tools and dashboards for processing, analyzing, querying, visualizing, and cleaning data.
Job description
Discover your role
- Liaise with Precision Medicine Quantitative Translational Sciences to analyze biomarker data types across a range of Precision Medicine and biomarker studies.
- Provide computational and technical expertise on data cleaning and data visualization.
- Integrate complex datasets to perform statistical analysis on exploratory biomarker data and clinical endpoints. Use technical tools, language, or custom coding and systems analysis to clean data and select or create datasets for analysis.
- Understand and follow data quality concepts and best practices and tools. Identify data anomalies and work with data stewards in other units to perform root cause analysis on data quality issues.
- Assist in the preparation of scientific presentations, manuscripts, and reports, including the preparation of quality checked tables and graphs depicting research results.
- Effectively communicate analytical plans and timelines for multiple concurrent projects with study team members.
- Develop, benchmark, and implement new computational workflows as necessary.
- Maintain best coding and data cataloguing practices for business consistency and scientific reproducibility.
This role requires
- PhD, or Masters with minimum 2 years of relevant work experience in one of the following or otherwise related quantitative fields: Computer Science, Computational Biology, Systems Biology, Quantitative Biology, Bioinformatics, Data Analytics, Statistics, Biostatistics, Mathematics, Applied Mathematics, Physics, Chemistry.
- Experience with statistical modeling/regression, machine learning, and other relevant data blending abilities.
- Experience in at least one of the following scripting languages: R, Python, MATLAB. Other languages such as SQL, Spark, and C++ are a bonus.
- Experience working in a Linux and/or cloud, shell scripting, and notebook environment.
- Knowledge of structured data, with the ability to perform data mapping for systems integration, data provisioning, and data consumption (strongly preferred).
- Working knowledge of clinical trials (strongly preferred).
Requirements
- PhD, or Masters with minimum 2 years of relevant work experience in a quantitative field such as Computer Science, Computational Biology, Systems Biology, Quantitative Biology, Bioinformatics, Data Analytics, Statistics, Biostatistics, Mathematics, Applied Mathematics, Physics, or Chemistry
- Experience with statistical modeling/regression, machine learning, and other relevant data blending abilities
- Experience in at least one of the following scripting languages: R, Python, MATLAB
- Experience working in a Linux and/or cloud, shell scripting, and notebook environment
- Knowledge of structured data, with the ability to perform data mapping for systems integration, data provisioning, and data consumption (strongly preferred)
- Working knowledge of clinical trials (strongly preferred)
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.